Cellular signalling of the receptor for advanced glycation end products (RAGE).
about
RAGE Expression and ROS Generation in Neurons: Differentiation versus DamageBiomarkers and Targeted Therapy in Pancreatic CancerBioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connectionRegulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesisDealing with Danger in the CNS: The Response of the Immune System to Injury.Differential effects of glycation on protein aggregation and amyloid formation.Scavenger receptor structure and function in health and disease.Long-term electrical stimulation at ear and electro-acupuncture at ST36-ST37 attenuated COX-2 in the CA1 of hippocampus in kainic acid-induced epileptic seizure rats.Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway.Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death.Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia.Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro.Selective Inhibition on RAGE-binding AGEs Required by Bioactive Peptide Alpha-S2 Case in Protein from Goat Ethawah Breed Milk: Study of Biological Modeling.Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy.Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis.Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular CarcinomaAdvanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/ExtracDiabetes and Its Effect on Bone and Fracture Healing.Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.Uremic Toxicity of Advanced Glycation End Products in CKD.RAGE gene polymorphism and environmental factor in the risk of oral cancer.Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease.Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancerSerum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4.Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases.Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care.Potential contribution of type I alveolar epithelial cells to chronic neonatal lung disease.Complexity of danger: the diverse nature of damage-associated molecular patterns.DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARγ/NFκB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts.Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.Targeting danger-associated molecular patterns after myocardial infarction.Hyperbaric oxygen therapy of spinal cord injury.
P2860
Q26744630-A1C27BC6-1ADD-4AE5-A824-4B3D2519B5BBQ26752755-C977ABB4-6CFD-4878-9AB0-E47FA891048FQ26822410-E7D74663-2CFA-4D1F-B40D-DBBD58F654BBQ28910474-6BDB1330-C26E-45B9-B846-478D355D26D0Q30279070-F94E925C-5E80-44C6-8244-2AC6790BADC3Q30374807-80B5B1EE-A1E1-463C-ABCA-F5BBE4585F70Q30958610-DBF816F3-8212-4A9F-B6F4-52CFE45689FAQ33674451-8A3F086A-6F31-4D73-80DD-0EE4B41AD70EQ33699731-E961B208-04F7-49E4-9AC0-234DA60D7F28Q34473695-15A24904-0887-428B-9B7D-8CAA9902E5B6Q35097737-B0836420-9746-4F1F-B125-8A11096129F7Q35164703-BFF3DBA5-8A54-4325-9B97-8E5937274C96Q35206138-7454FC87-D52F-4EDD-87F8-169A2941AEB8Q35538065-27FB4571-55CF-45D7-BADB-B5E6EA10B2A9Q35592681-118167CC-42C9-4CD4-83FF-E2D6D51D47AEQ35600704-3C814CAC-2F6A-4F31-8143-65B5C787CA79Q35601343-23EF140E-798D-4BF5-A675-F3CFD6B79A03Q35644521-71129B68-148B-4AE1-B261-E7306142D71DQ35750862-C4B71A85-3AF6-4FD3-9D9D-6F26393EF1DEQ35814925-1D896647-1917-4CC5-AFE5-B3E9681771CAQ36146033-991CBE9E-3523-4A77-85E7-5D67EACE6011Q36153175-848A655C-321C-486E-8933-64227DE144CDQ36301271-EF8C4701-E491-4D3D-8B9B-6C1FBBA828A3Q36407732-65A95F58-6BBA-41C6-AC2D-9BA5238FE738Q36477852-908AA8BC-E80A-41C3-8642-AEC9D97AD258Q36514906-6A20F2B4-A135-44F5-AFB0-2A018BB1C590Q36745763-8D54F245-ECA0-4C74-AE45-728B21F75C49Q36826342-623C09A6-2584-4207-91D7-FAEDE32C7844Q37396756-5A7C7A16-C5A4-4490-82F6-39BCFBAB18D6Q37619731-75C026E8-4B56-410C-816D-9C102DCE2A61Q37729999-47BA1162-9914-4D3F-97A7-CB18E25C979BQ38182068-55BF5532-E085-4DC8-8B16-20599906095BQ38215937-DDC5EB8E-8D9A-41CA-B588-25F2AB5F1C3BQ38218137-E6FBC500-9DB3-4FAC-B9A3-0F6F43BDC113Q38267715-9F867404-BF60-4375-B8AF-FAA9D9093B53Q38301652-3328C703-3AC9-44A1-A9F2-B8AD0A4E92ABQ38315999-76CE3408-5B7E-41A6-923A-B8E12351AE01Q38541559-1A14C733-9A6F-4B70-8E1C-B292F6C83213Q38595544-B93A5AE2-401C-447D-8B78-0631C0A65F90Q38651796-5487DF3D-684A-4756-B2CA-96651DF614D1
P2860
Cellular signalling of the receptor for advanced glycation end products (RAGE).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cellular signalling of the receptor for advanced glycation end products (RAGE).
@en
type
label
Cellular signalling of the receptor for advanced glycation end products (RAGE).
@en
prefLabel
Cellular signalling of the receptor for advanced glycation end products (RAGE).
@en
P1433
P1476
Cellular signalling of the receptor for advanced glycation end products (RAGE)
@en
P2093
María Montserrat Aguilar-Hernández
Verna Méndez-Valenzuela
P304
P356
10.1016/J.CELLSIG.2013.06.013
P577
2013-07-06T00:00:00Z